Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Roche's New Elecsys Dengue Ag Test Achieves CE Mark, Delivering 18-Minute Results And High Clinical Sensitivity Across All Four Virus Serotypes

Author: Benzinga Newsdesk | October 29, 2025 02:18am

New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute fever-causing illnesses.
Full automation facilitates medium to high throughput and enables improvement of lab efficiency and test traceability, while reducing the risk of human error.
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks.

Posted In: RHHBF RHHBY RHHVF